Anti-nephrin Antibody: a Potential Biomarker of Minimal Change Disease

Overview

Journal Clin Kidney J

Publisher Oxford University Press

Specialty Nephrology

Date 2025 Mar 6

PMID 40046822

Authors

Qiaoling Chen

Sihui Chen

Qiuping Ye

Wanjun Lin

Yonggen Liao

Yunfeng Xiong

Jiaming Xu

Ruiyu Gao

Binbin Li

Lifang Liu

Lixin Wei

Affiliations

Soon will be listed here.

Abstract

Background: Minimal change disease (MCD) is a common pathological type of nephrotic syndrome in children and adults, and the mechanisms remain obscure. The diagnosis of MCD still relies on renal biopsy, lacking effective biological markers. This study explores the diagnostic value of circulating anti-nephrin antibody in MCD patients and evaluates the correlation with disease activity indicators such as proteinuria.

Methods: The study included 108 adult patients with glomerular disease, including 36 with MCD, 16 with primary focal segmental glomerulosclerosis (FSGS), 20 with primary membranous nephropathy (MN), 17 with diabetic nephropathy (DN) and 19 with immunoglobulin A nephropathy (IgAN). Twenty healthy volunteers were included. Circulating anti-nephrin antibody was detected by indirect immunofluorescence method of cell-based assay. The receiver-operating characteristic (ROC) curve was used to evaluate the role of circulating anti-nephrin antibody in the diagnosis of MCD. The correlations between anti-nephrin antibody and clinical parameters were analyzed.

Results: The prevalence of circulating anti-nephrin antibody was 19.44% (7 of 36) in MCD and 26.92% (7 of 26) in MCD patients with nephrotic proteinuria, which was higher than in FSGS, PMN, DN, IgAN and healthy volunteers. The ROC curve showed that the sensitivity of anti-nephrin antibody used in the diagnosis of MCD was 19.4% and the specificity was 97.8%. The MCD patients with positive anti-nephrin antibody had heavier proteinuria and higher serum lipid levels, while having lower serum albumin and blood IgG levels. Anti-nephrin antibody might turn to negative when the MCD patient had a response to therapy.

Conclusions: Circulating anti-nephrin antibody may be a potential biomarker of MCD and may play a role in the MCD diagnosis.

References

Chebotareva N, Vinogradov A, Birukova Y, Alentov I, Sergeeva N, Chemodanova D . A pilot study of anti-nephrin antibodies in podocytopaties among adults. Nephrology (Carlton). 2023; 29(2):86-92. DOI: 10.1111/nep.14249. View

Kawashima N, Naito S, Hanamatsu H, Nagane M, Takeuchi Y, Furukawa J . Glycosphingolipid GM3 prevents albuminuria and podocytopathy induced by anti-nephrin antibody. Sci Rep. 2022; 12(1):16058. PMC: 9513075. DOI: 10.1038/s41598-022-20265-w. View

Giannou P, Gakiopoulou H, Stambolliu E, Petras D, Chalkia A, Kapota A . Urine Nephrin and Podocalyxin Reflecting Podocyte Damage and Severity of Kidney Disease in Various Glomerular Diseases-A Cross-Sectional Study. J Clin Med. 2024; 13(12). PMC: 11205118. DOI: 10.3390/jcm13123432. View

Kandasamy Y, Smith R, Lumbers E, Rudd D . Nephrin - a biomarker of early glomerular injury. Biomark Res. 2015; 2:21. PMC: 4363192. DOI: 10.1186/2050-7771-2-21. View

Sun Y, Li Z, Sun J, Zhang S, Wang R, Chen B . The efficacy and safety of rituximab with or without glucocorticoid in inducing remission of MCD with different clinical presentations in adults: a retrospective study. Clin Kidney J. 2024; 17(6):sfae139. PMC: 11161702. DOI: 10.1093/ckj/sfae139. View

New L, Keyvani Chahi A, Jones N . Direct regulation of nephrin tyrosine phosphorylation by Nck adaptor proteins. J Biol Chem. 2012; 288(3):1500-10. PMC: 3548463. DOI: 10.1074/jbc.M112.439463. View

Vivarelli M, Massella L, Ruggiero B, Emma F . Minimal Change Disease. Clin J Am Soc Nephrol. 2016; 12(2):332-345. PMC: 5293332. DOI: 10.2215/CJN.05000516. View

Sui W, Zhang R, Chen J, He H, Cui Z, Ou M . Comparative proteomic analysis of membranous nephropathy biopsy tissues using quantitative proteomics. Exp Ther Med. 2015; 9(3):805-810. PMC: 4316945. DOI: 10.3892/etm.2015.2197. View

Watts A, Keller K, Lerner G, Rosales I, Collins A, Sekulic M . Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology. J Am Soc Nephrol. 2021; 33(1):238-252. PMC: 8763186. DOI: 10.1681/ASN.2021060794. View

10.

Doublier S, Ruotsalainen V, Salvidio G, Lupia E, Biancone L, Conaldi P . Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol. 2001; 158(5):1723-31. PMC: 1891937. DOI: 10.1016/S0002-9440(10)64128-4. View

11.

Wang C, Zhang M, Li L, Yun X, Chen C, Wang F . Ultra-low-dose rituximab is effective for the treatment of patients with minimal change disease - A retrospective study. J Formos Med Assoc. 2024; . DOI: 10.1016/j.jfma.2024.06.013. View

12.

Barar A, Pralea I, Maslyennikov Y, Munteanu R, Berindan-Neagoe I, Pirlog R . Minimal Change Disease: Pathogenetic Insights from Glomerular Proteomics. Int J Mol Sci. 2024; 25(11). PMC: 11171934. DOI: 10.3390/ijms25115613. View

13.

New L, Martin C, Scott R, Platt M, Keyvani Chahi A, Stringer C . Nephrin Tyrosine Phosphorylation Is Required to Stabilize and Restore Podocyte Foot Process Architecture. J Am Soc Nephrol. 2016; 27(8):2422-35. PMC: 4978059. DOI: 10.1681/ASN.2015091048. View

14.

Liu L, Qin Y, Cai J, Wang H, Tao J, Li H . Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome. Clin Immunol. 2011; 139(3):314-20. DOI: 10.1016/j.clim.2011.02.018. View

15.

Takeuchi K, Naito S, Kawashima N, Ishigaki N, Sano T, Kamata K . New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse Strain. Nephron. 2017; 138(1):71-87. DOI: 10.1159/000479935. View

16.

Kopp J, Anders H, Susztak K, Podesta M, Remuzzi G, Hildebrandt F . Podocytopathies. Nat Rev Dis Primers. 2020; 6(1):68. PMC: 8162925. DOI: 10.1038/s41572-020-0196-7. View

17.

Hengel F, Dehde S, Lasse M, Zahner G, Seifert L, Schnarre A . Autoantibodies Targeting Nephrin in Podocytopathies. N Engl J Med. 2024; 391(5):422-433. DOI: 10.1056/NEJMoa2314471. View

18.

Furness P, Hall L, Shaw J, Pringle J . Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome. Nephrol Dial Transplant. 1999; 14(5):1234-7. DOI: 10.1093/ndt/14.5.1234. View

19.

Kocylowski M, Aypek H, Bildl W, Helmstadter M, Trachte P, Dumoulin B . A slit-diaphragm-associated protein network for dynamic control of renal filtration. Nat Commun. 2022; 13(1):6446. PMC: 9616960. DOI: 10.1038/s41467-022-33748-1. View

20.

Yoshida S, Wei X, Zhang G, OConnor C, Torres M, Zhou Z . Endoplasmic reticulum-associated degradation is required for nephrin maturation and kidney glomerular filtration function. J Clin Invest. 2021; 131(7). PMC: 8011890. DOI: 10.1172/JCI143988. View